Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 1044Neoplasms 876Prostatic Neoplasms 507Lung Neoplasms 422Colorectal Neoplasms 358Motor Activity 220Head and Neck Neoplasms 194Uterine Cervical Neoplasms 190Carcinoma, Non-Small-Cell Lung 180Brain Neoplasms 173Pancreatic Neoplasms 160Ovarian Neoplasms 138Colonic Neoplasms 137Carcinoma, Hepatocellular 136Anxiety Disorders 124Rectal Neoplasms 117Hematologic Neoplasms 115Multiple Myeloma 106Stomach Neoplasms 103Neoplasm Metastasis 99Precursor Cell Lymphoblastic Leukemia-Lymphoma 94Depression 93Melanoma 92Urinary Bladder Neoplasms 88Pain 87Endometrial Neoplasms 86Glioblastoma 84Disease 83Lymphoma 81Sarcoma 78

Interventions

Diffusion Magnetic Resonance Imaging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Li-Fraumeni Syndrome × 1 year × Clear all
NCT03176836 2026-04-29

Li-Fraumeni Syndrome Imaging Study

The Hospital for Sick Children

Phase NA Enrolling by invitation
30 enrolled

Li-Fraumeni Syndrome

NCT02950987 2026-01-07

Screening With Whole Body MRI For Detection Of Primary Tumors In Children And Adults With Li-Fraumeni Syndrome (LFS) And Other Cancer Predisposition Syndromes

Dana-Farber Cancer Institute

Phase NA Active not recruiting
150 enrolled

Li-Fraumeni Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡